Group 1 - The company Meili Tianyuan Medical Health (02373) announced the investment of idle funds through its non-wholly owned subsidiary Beijing Beilish, subscribing to a principal-protected financial product from Shanghai Pudong Development Bank with a total amount of RMB 80 million on February 13, 2026 [1] - Additionally, the company, through Beijing Beilish and Shanghai Meili Tianyuan Medical Health, subscribed to financial products from Shanghai Pudong Development Bank for RMB 70 million on November 21, 2025; RMB 10 million on November 28, 2025; and RMB 80 million on December 30, 2025 [1] - All the aforementioned financial products are still outstanding as of the date of the announcement [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373.HK) announced the investment of idle funds into a principal-protected financial product from Shanghai Pudong Development Bank, amounting to RMB 80 million [1] Group 1 - The board of directors has made a decision to effectively utilize idle funds [1] - The investment is made by the non-wholly owned subsidiary Beijing Beili Shi [1] - The financial product subscription date is set for February 13, 2026 [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373) announced the investment of idle funds into principal-protected financial products from Pudong Development Bank, totaling RMB 80 million [1] Group 1: Investment Details - The company’s non-wholly owned subsidiary, Beijing Beilish, subscribed to a principal-protected financial product from Pudong Development Bank for a total amount of RMB 80 million on February 13, 2026 [1] - Additionally, the company, through Beijing Beilish and Shanghai Meili Tianyuan Medical Health, subscribed to several other principal-protected financial products from Pudong Development Bank, including RMB 70 million on November 21, 2025, RMB 10 million on November 28, 2025, and RMB 80 million on December 30, 2025 [1] - All the aforementioned financial products are still outstanding as of the date of the announcement [1]

Group 1 - The company, Meili Tianyuan Medical Health (02373), announced the investment of idle funds through its non-wholly owned subsidiary, Beijing Beilish, by subscribing to a principal-protected financial product from Pudong Development Bank with a total amount of RMB 80 million on December 30, 2025 [1] - Additionally, the company subscribed to several financial products from Pudong Development Bank through Beijing Beilish and Shanghai Meili Tianyuan Medical Health, including RMB 10 million on November 28, 2025, RMB 70 million on November 21, 2025, and RMB 80 million on October 9, 2025, all of which are still outstanding as of the announcement date [1]

Group 1 - The company, Meili Tianyuan Medical Health (02373), announced the investment of idle funds through its non-wholly owned subsidiary, Beijing Beilish, by subscribing to a principal-protected financial product from Shanghai Pudong Development Bank with a total amount of RMB 80 million on December 30, 2025 [1] - Additionally, the company, through Beijing Beilish and Shanghai Meili Tianyuan Medical Health, subscribed to several financial products from Shanghai Pudong Development Bank, including RMB 10 million on November 28, 2025, RMB 70 million on November 21, 2025, and RMB 80 million on October 9, 2025 [1] - All the aforementioned financial products are still outstanding as of the date of the announcement [1]

Core Viewpoint - Meili Tianyuan Medical Health (02373.HK) announced the investment of idle funds into principal-protected financial products from Pudong Development Bank, totaling RMB 80 million as of December 30, 2025 [1] Group 1: Investment Details - The company, through Beijing Beilish and Shanghai Meili Tianyuan Medical Health, subscribed to a principal-protected financial product from Pudong Development Bank for RMB 10 million on November 28, 2025 [1] - Additionally, the company subscribed for RMB 70 million on November 21, 2025, and RMB 80 million on October 9, 2025, all from Pudong Development Bank [1] - All aforementioned financial products remain outstanding as of the announcement date [1]

Group 1 - The company plans to use up to 55 million yuan of idle self-owned funds to purchase low-risk principal-protected financial products offered by financial institutions [2] - The investment will have a rolling usage period of 12 months from the date of approval by the shareholders' meeting [2] - The proposal has been approved by the company's 11th Board of Directors at the 11th meeting of 2025 and is pending approval from the shareholders' meeting [2]

Core Viewpoint - The company plans to invest up to 550 million yuan of idle funds in liquid, low-risk principal-protected financial products offered by financial institutions, pending shareholder approval [1] Group 1 - The investment will be valid for 12 months from the date of approval by the shareholders' meeting [1] - The board of directors has already approved this decision in its 11th meeting of the 2025 session [1] - The investment amount can be used in a rolling manner within the approved limit [1]

Core Insights - The Federal Reserve's recent 25 basis point rate cut has led to confusion in the market rather than the anticipated excitement, as the stock market showed only a brief bounce before settling into a state of watchful waiting [1][3] - The internal divisions within the Federal Reserve, highlighted by dissenting votes among its members, have contributed to market unease, signaling uncertainty about future policy directions [3][4] Market Reactions - The 25 basis point cut did not meet market expectations, as many traders had anticipated a more aggressive 50 basis point reduction due to weak employment data [3][4] - The stock market's response has been muted, with concerns about the overall economic outlook overshadowing the potential benefits of lower interest rates [6][11] Implications for Stakeholders - For households with mortgages, the rate cut may provide some relief as it could lead to lower mortgage rates, creating a potential window for refinancing [6] - Investors in the stock market may face a complex situation, as historical trends suggest that initial rate cuts typically benefit stocks, particularly in the tech sector, but current economic fears may counteract this effect [6][11] - Savers may need to prepare for declining bank deposit rates, which could erode the purchasing power of their savings [6] Global Impact - The rate cut has begun to affect global markets, with the U.S. dollar index declining, allowing emerging market currencies like the Chinese yuan to appreciate [9] - This shift in capital dynamics suggests a changing landscape for global asset allocation, as international investors seek new opportunities amid reduced attractiveness of dollar-denominated assets [9] Historical Context - The recent rate cut may be seen as a prelude to more significant economic challenges, as the U.S. economy grapples with a weak job market and emerging inflation pressures [11][12] - The interplay between political influences and monetary policy decisions raises questions about the Federal Reserve's independence and its implications for long-term economic stability [11][12]